Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Pregnancy
Intervention: Other: Observation
Sponsor: University of Luebeck
Not yet recruiting - verified March 2010
Condition: Hypoxemia
Intervention:
Sponsor: Covidien
Recruiting - verified March 2010
Condition: Transient Tachypnea
Intervention: Other: Prophylactic CPAP Administration
Sponsor: New York Hospital Queens
Recruiting - verified February 2010
Condition: Stem Cell Transplantation
Interventions: Biological: Auto-hMSCs; Biological: Allo-hMSCs
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); University of Miami
Not yet recruiting - verified October 2009
Condition: Preterm Birth
Intervention: Behavioral: i) Diffusing recommendations for antenatal corticosteroids use to healthcare providers
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); RTI International; Tulane University School of Medicine; Institute for Clinical Effectiveness and Health Policy; University of Alabama at Birmingham; University Teaching Hospital of Lusaka; University of Colorado, Denver; Center for Studies of Sensory Impairment, Aging and Metabolism (CeSSIAM); JN Medical College; Drexel University College of Medicine; Aga Khan University; Tufts University; Indiana University; Moi Univeristy; Indira Ghandi Government Medical College
Not yet recruiting - verified October 2008
Conditions: HIV; Infant, Newborn; Anemia; Neutropenia
Intervention: Drug: cotrimoxazole
Sponsors: Harvard School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID); John E. Fogarty International Center (FIC); Harvard Initiative for Global Health; American Society of Tropical Medicine and Hygiene
Recruiting - verified March 2010
Conditions: Anemia; Ferritin; Complications; Hemorrhage; Jaundice
Interventions: Procedure: Early Cord Clamping; Procedure: Delayed Cord Clamping
Sponsor: Aga Khan University
Enrolling by invitation - verified July 2008
Conditions: Pregnancy; Weight Gain
Interventions: Behavioral: Lifestyle Intervention group; Behavioral: Standard of Care
Sponsor: Emory University
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; University of California, San Diego; Organization of Teratology Information Specialists (OTIS)
Active, not recruiting - verified March 2010
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
Sponsors: Azienda Ospedaliero, Universitaria Meyer; Ospedale Maggiore Policlinico Mangiagalli e Regina Elena
Recruiting - verified February 2010
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Conditions: Hypertension, Pregnancy-Induced; Hypertension
Interventions: Drug: Labetalol or Methyldopa or Nifedipine or Hydralazine; Drug: Labetalol or Methyldopa or Nifedipine or Hydralazine
Sponsors: Hillel Yaffe Medical Center; University of British Columbia; CHIPS Trial Clinical Coordinating Center
Not yet recruiting - verified March 2010
Conditions: Cystic Fibrosis; Rhinosinusitis
Interventions: Drug: NaCl 6%; Drug: NaCl 0,9%
Sponsor: University of Jena
Not yet recruiting - verified March 2010
Condition: Malaria in Pregnancy
Interventions: Other: Intermittent screening and treatment of malaria in pregnancy (IST); Other: SP-IPTp
Sponsors: London School of Hygiene and Tropical Medicine; Medical Research and Training Centre, Mali; Université de Ouagadougou, Burkina Faso; Medical Research Council Laboratories, Gambia; Navrongo Health Research Centre, Ghana; Liverpool School of Tropical Medicine
Not yet recruiting - verified March 2010
Conditions: Conditions Involved in Maternal Morbidity and Mortality; Conditions Contributing to Stillbirth and Neonatal Deaths
Interventions: Behavioral: Community Mobilization; Behavioral: Home-based Life Saving Skills; Behavioral: Facility improvement
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2009
Condition: Pregnancy Outcome Trends in Low-resource Geographic Areas
Intervention: Other: There is no intervention associated with this study.
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2009
Conditions: Pyrexia; Abdominal Delivery
Intervention: Drug: Combined epidural and spinal anesthesia
Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
Active, not recruiting - verified December 2007
Condition: Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Interventions: Drug: TOBI; Drug: Placebo to TOBI
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Conditions: PPHN; Neonates; Sildenafil
Intervention: Drug: sildenafil
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin; Drug: Ibuprofen
Sponsor: Shaare Zedek Medical Center
Not yet recruiting - verified February 2010
Condition: Pregnancy
Intervention:
Sponsor: Universitaire de Sherbrooke
Recruiting - verified February 2010
Condition: Cystic Fibrosis
Intervention:
Sponsors: CF Therapeutics Development Network Coordinating Center; Cystic Fibrosis Foundation
Recruiting - verified March 2010
Conditions: Diarrhea; Acute Respiratory Infection
Interventions: Dietary Supplement: milk supplement 1; Dietary Supplement: milk supplement 2
Sponsors: Nestlé Nutrition Corporate; University of the Philippines
Not yet recruiting - verified February 2010
Conditions: Cirrhosis; Liver Fibrosis; Portal Hypertension; Cystic Fibrosis; Parenteral Nutrition
Intervention: Other: Elastometry
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2010
Condition: Diabetes in Cystic Fibrosis Patients
Intervention: Other: Prospective cohort with an annual follow-up
Sponsor: Hospices Civils de Lyon
Recruiting - verified October 2009
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
Sponsor: Sheba Medical Center
Not yet recruiting - verified February 2010
Conditions: Pulmonary Infections; Pseudomonas Aeruginosa
Intervention: Drug: Tobramycin inhalation powder
Sponsor: Novartis Pharmaceuticals
Enrolling by invitation - verified February 2010